Geode Capital Management
BNGO icon

Geode Capital Management’s Bionano Genomics BNGO Stock Holding History

Geode Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Sell
89,993
-77,540
-46% -$93.4K ﹤0.01% 4097
2026
Q1 		$196K Buy
167,533
+100,767
+151% +$129K ﹤0.01% 3925
2025
Q4 		$102K Buy
66,766
+39,928
+149% +$69.1K ﹤0.01% 4092
2025
Q3 		$45.9K Buy
26,838
+7,967
+42% +$25.3K ﹤0.01% 4310
2025
Q2 		$61.9K Buy
18,871
+3,365
+22% +$12.6K ﹤0.01% 4169
2025
Q1 		$43.3K Sell
15,506
-1,122
-7% -$7.34K ﹤0.01% 4225
2024
Q4 		$288K Buy
16,628
+1,914
+13% +$32.7K ﹤0.01% 3781
2024
Q3 		$401K Buy
14,714
+4,727
+47% +$147K ﹤0.01% 3681
2024
Q2 		$406K Buy
9,987
+3,297
+49% +$181K ﹤0.01% 3647
2024
Q1 		$446K Buy
6,690
+410
+7% +$30.6K ﹤0.01% 3660
2023
Q4 		$712K Buy
6,280
+580
+10% +$60.6K ﹤0.01% 3476
2023
Q3 		$1.04M Buy
5,700
+718
+14% +$188K ﹤0.01% 3303
2023
Q2 		$1.82M Sell
4,982
-4,675
-48% -$2.11M ﹤0.01% 3141
2023
Q1 		$6.43M Buy
9,657
+405
+4% +$360K ﹤0.01% 2519
2022
Q4 		$8.1M Buy
9,252
+484
+6% +$609K ﹤0.01% 2398
2022
Q3 		$9.63M Buy
8,768
+181
+2% +$239K ﹤0.01% 2292
2022
Q2 		$7.11M Buy
8,587
+1,266
+17% +$1.3M ﹤0.01% 2483
2022
Q1 		$11.3M Sell
7,321
-537
-7% -$725K ﹤0.01% 2268
2021
Q4 		$14.1M Buy
7,858
+71
+0.9% +$190K ﹤0.01% 2208
2021
Q3 		$25.7M Sell
7,787
-32
-0.4% -$112K ﹤0.01% 1780
2021
Q2 		$34.4M Buy
7,819
+5,026
+180% +$19.8M ﹤0.01% 1614
2021
Q1 		$13.5M Buy
2,793
+1,219
+77% +$6.87M ﹤0.01% 2142
2020
Q4 		$2.91M Buy
1,574
+547
+53% +$204K ﹤0.01% 2881
2020
Q3 		$400K Buy
1,027
+492
+92% +$191K ﹤0.01% 3490
2020
Q2 		$163K Buy
535
+123
+30% +$30.9K ﹤0.01% 3714
2020
Q1 		$112K Sell
412
-9
-2% -$5.08K ﹤0.01% 3728
2019
Q4 		$313K Buy
+421
New +$246K ﹤0.01% 3658

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Geode Capital Management's BNGO Position: Q2 2026 in Review

Geode Capital Management reduced its Bionano Genomics (BNGO) stake by 46% in Q2 2026, selling an estimated $93.4K and leaving 89,993 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #4097.

Geode Capital Management first reported a position in BNGO in Q4 2019 and has held it in 27 quarters since. The position peaked at $34.4M in Q2 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Geode Capital Management held 89,993 shares of Bionano Genomics worth $102K as of Q2 2026.
  • Geode Capital Management sold 77,540 Bionano Genomics shares in Q2 2026, an estimated $93.4K.
  • Bionano Genomics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4097 holding.
  • Geode Capital Management first reported a position in Bionano Genomics in Q4 2019 and has held it in 27 quarters since.
  • Geode Capital Management's Bionano Genomics position peaked at $34.4M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.